Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, July 31, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
SCHOTT Assists the Pharmaceutical Industry on Tracking Pharmaceutical Tubing
Thursday, January 23, 2014
Company issues its 1 millionth certificate for its FIOLAX® glass tubing.

FDA, EMA Extend Licenses for Aptiv Solutions ADDPLAN® Software
Wednesday, January 08, 2014
FDA purchases novel ADDPLAN® DF Software for improved evaluation of Phase II dose-finding trials.

EyeTechCare Doubles the Number of Health Care Facilities in France with the EyeOP1 Device
Thursday, January 02, 2014
The EyeOp1 device is now available in ten centers across France, with this figure expected to double in 2014.

TELOS MicroPlate™ from Kinesis – a versatile 96-well SPE format for small volume biological fluid samples
Monday, December 16, 2013
The TELOS MicroPlate™ is a versatile 96-well plate for the extraction of drug molecules from small volume biological fluid samples.

New UK mHealth Congress Announced for 2014
Tuesday, November 19, 2013
MCT-Congress will bring together key influencers to drive the business of mHealth in clinical research.

Phenom-World Launches the New Particlemetric Software for Fully Automated Inspection and Analysis of Particles
Tuesday, November 12, 2013
With the introduction of the ParticleMetric software, the visualization and analysis of particles are easier than ever before with the Phenom desktop SEM.

Nov 20 Best Practices IV: Preclinical Outsourcing Program/Simulcast
Monday, November 11, 2013
Preclinical outsourcing program/simulcast at Ocean Place in Long Branch, NJ, and via Webinar.

Quotient Clinical at AAPS 2013
Friday, November 08, 2013
AAPS annual meeting and exposition to be held in San Antonio, Texas, from the 10th to the 14th of November.

Aesica Introduces Aseptic Micro Dosing Capabilities at Nottingham Site
Tuesday, November 05, 2013
New technology (3P Fill2Weight) reduces development cycle and can be used with capsules, vials, inhalers, injectables, blisters and even high potents.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 290
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv